MSD Korea launches novel carbapenem antibiotic

MSD Korea, a Korean business unit of a multinational pharmaceutical firm, said it launched Invanz injection (ertapenem sodium), a novel carbapenem antibiotic for the treatment of complicated intra-abdominal infections and complicated skin/skin structure infections.

Ertapenem sodium inhibits the bacteria from producing its cell wall, which causes the death of the bacteria and is indicated for...